Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
31.79
+0.20 (0.63%)
At close: Jan 22, 2026, 4:00 PM EST
32.42
+0.63 (1.98%)
After-hours: Jan 22, 2026, 5:05 PM EST
Upstream Bio Employees
Upstream Bio had 52 employees as of December 31, 2024.
Employees
52
Change
n/a
Growth
n/a
Revenue / Employee
$53,827
Profits / Employee
-$2,611,827
Market Cap
1.72B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 52 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 493 |
| MannKind | 407 |
| Biohaven | 256 |
| Celldex Therapeutics | 186 |
| Stoke Therapeutics | 128 |
| Kodiak Sciences | 109 |
| Pharvaris | 108 |
| Enliven Therapeutics | 62 |
UPB News
- 17 days ago - Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study - Seeking Alpha
- 2 months ago - Upstream Bio to Participate in Upcoming December Investor Conferences - GlobeNewsWire
- 2 months ago - Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress - GlobeNewsWire
- 2 months ago - Upstream Bio to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 4 months ago - Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug's Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress - GlobeNewsWire
- 4 months ago - Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum - GlobeNewsWire
- 4 months ago - Upstream Bio, Inc. - Special Call - Seeking Alpha